Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies

Clinical trial NCT00153985 · COMPLETED

Trial details

NCT number: NCT00153985
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hemoglobinopathies Sickle Cell Disease Thalassemia

Start date: 2004-03-01
Primary completion: 2008-03-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.